Novo Nordisk (Privately Held; Venture Capital & Private Equity industry): Director, (June 2008-Present) Head of Translational Immunology at Novo Nordisk A/S. Better (pre)clinical research is required to reduce the attrition rate of clinical stage drug-development programs. T...
Linkedin